Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Miniaturized Clinical Test Rapidly Detects Antibiotic Resistance

By LabMedica International staff writers
Posted on 07 Sep 2016
A new microfluidic concept for multi-analyte testing in a dipstick format, termed “Lab-on-a-Stick”, that combines the simplicity of dipstick tests with the high performance of microfluidic devices has been developed.

Lab-on-a-stick tests are ideally suited to analysis of particulate samples such as mammalian or bacterial cells and capable of performing multiple different parallel microfluidic assays when dipped into a single sample with results recorded optically and a portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed.

Scientists at Loughborough University (UK) and their colleagues carried out different cellular tests to demonstrate the full potential of Lab-on-a-Stick devices for a range of clinical situations. More...
The utility of this new diagnostics format was demonstrated by performing three types of multiplex cellular assays that are challenging to perform in conventional dipsticks: instantaneous ABO blood typing; microbial identification; and antibiotic minimum inhibitory (MIC) concentration measurement.

Anti-microbial resistance was measured with Escherichia coli samples typical of common urinary tract infection (UTIs). UTIs can be hard to treat with antibiotics because antibiotic resistance is so common and laboratory testing takes at least two days. The team demonstrated the advantage of using the microcapillary film which enables 10 different concentrations of antibiotic per sample to be tested with a single test strip.

To identify bacteria, many different tests must be performed on every sample, illustrating again the benefits of microcapillary film which performs 10 tests per test strip. This study demonstrated a four-hour test to distinguish two very closely related bacteria, a harmless laboratory strain of E. coli from Salmonella enterica that causes food poisoning. For ABO blood typing, a simple blood test that takes only two minutes was miniaturized and the results were recorded using an everyday digital camera.

Alexander D. Edwards, PhD, an associate professor and co-author of the study, said, “This is the latest demonstration of our exciting new technology called microcapillary film. What we have done is to develop a low cost way of making thousands of miniature test tubes, so that we can use them for many important applications. Lab-on-a-Stick shows yet again how versatile these microscopic test tubes are.” The study was first published online on June 23, 2016, in the journal Lab on a Chip.

Related Links:
Loughborough University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.